To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Public ClinicalTrials.gov record NCT01300208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Pilot, Multicenter, Sequential, Ascending Dose Study to Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Study identification
- NCT ID
- NCT01300208
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- CC-11050 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010
- Primary completion
- Dec 31, 2012
- Completion
- Feb 28, 2013
- Last update posted
- Jun 22, 2020
2010 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Clinical Trials Center, PLLC | Rogers | Arkansas | 72758 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Medderm Associates | San Diego | California | 92103 | — |
| Emory Univ. School of Medicine | Atlanta | Georgia | 30322 | — |
| Peachtree Dermatology Associates Research Center | Atlanta | Georgia | 30327 | — |
| Central Medaphase Inc | Newnan | Georgia | 30263 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| DermResearch, PLLC | Louisville | Kentucky | 40217 | — |
| Dermatology & Advanced Aesthetics | Lake Charles | Louisiana | 70605 | — |
| Central Dermatology, P.C. | St Louis | Missouri | 63117 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Penn State Hershey Dermatology | Hershey | Pennsylvania | 17033 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| UT Southwestern Medical Center Dallas | Dallas | Texas | 75390-9090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01300208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2020 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01300208 live on ClinicalTrials.gov.